Skip to content
★ Sign in to follow
GS

Gary Sphar

Mylan Laboratories Inc
Total declarations
2
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (1 ops.)
€136k

Latest filing published 19 Sept 2006 for MYLAN LABORATORIES INC, €74k.

Insider track record

Disclosed buys
0
Disclosed sells
1
Signal history

No signal scores available.

Gary Sphar: trading record in brief

Gary Sphar discloses dealings in Mylan Laboratories Inc to SEC (Form 4). In total, 2 filings cover trades dated 15 September 2006.

No open-market purchase appears, only 1 sale worth €136k. Besides market trades, the filings include 1 option exercise.

The record was last updated on 19 September 2006 with an option exercise (€74k) in Mylan Laboratories Inc. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Gary Sphar

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ◇
    CFO, Mylan Pharmaceuticals IncExecutivesMylan Laboratories Inc
    93,798 USD0SEC
    8,100 shares@ US$11.58Common StockSEC:0000069499-06-000030:0
  • ▼
    CFO, Mylan Pharmaceuticals IncExecutivesMylan Laboratories Inc
    171,720 USD0SEC
    8,100 shares@ US$21.20Common StockSEC:0000069499-06-000030:1

2 of 2 declarations